govt.fyi
Back to SB 29
Oklahoma Legislature· SB 29Second Reading referred to Health and Human Services

An act relating to health care, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Oklahoma Legislature, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
1                          STATE OF OKLAHOMA

1

2                 1st Session of the 60th Legislature (2025)

2

3 SENATE BILL 29           By: Hamilton
3

4

4

5

5

6                          AS INTRODUCED

6

7   An Act relating to health care; requiring licensed

7   practitioners to offer pharmacogenomic test prior to

8   prescription of psychotropic drugs; requiring certain

8   disclosures and obtainment of informed consent;

9   directing order and administration of pharmacogenomic

9   test; providing for codification; and providing an

10  effective date.

10

11

11

12

12

13 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
13

14  SECTION 1.    NEW LAW  A new section of law to be codified

14

15 in the Oklahoma Statutes as Section 7201 of Title 63, unless there
15

16 is created a duplication in numbering, reads as follows:
16

17  A. A licensed practitioner shall, prior to the prescription of

17

18 any psychotropic drug to a patient, offer to administer a
18

19 pharmacogenomic test to the patient for the purpose of guiding the
19

20 decisions of the licensed practitioner with respect to how the
20

21 patient's genes may react to certain medications.
21

22  B. The licensed practitioner shall, to the best of the licensed

22

23 practitioner's knowledge, inform the patient of the efficacy of
23

24 pharmacogenomic testing. The licensed practitioner shall inform the
24

    Req. No. 496                                              Page 1
1 patient of whether or not the pharmacogenomic test to be
1

2 administered is approved by the United States Food and Drug
2

3 Administration. The licensed practitioner shall obtain the
3

4 patient's informed consent prior to ordering a pharmacogenomic test.
4

5 If the practitioner is aware of the cost of the pharmacogenomic
5

6 test, the practitioner shall provide an estimate to the patient of
6

7 such cost.
7

8   C. If a patient provides informed consent to receive a

8

9 pharmacogenomic test, the licensed practitioner shall order the
9

10 pharmacogenomic test and administer such test to the patient prior
10

11 to the prescription of any psychotropic medication.
11

12  SECTION 2. This act shall become effective November 1, 2025.

12

13

13

14  60-1-496      DC  12/16/2024 12:38:56 PM

14

15

15

16

16

17

17

18

18

19

19

20

20

21

21

22

22

23

23

24

24

    Req. No. 496                                               Page 2
Every fact on this page links to its source, starting with the official bill record.